Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Imperial College London.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Medical Research Council
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00146952
First received: September 5, 2005
Last updated: April 16, 2007
Last verified: September 2005
  Purpose

The investigators propose to explore the hypothesis that vibrotactile channels for indicating spatial orientation can be exploited as a sensory prosthesis. The specific research applications will be used for guiding visual orientation, to provide alternative feedback to vision and vestibular signals for controlling balance, and for directional and lateralisation cueing in patients with neglect syndromes. The programme will study whether vibrotactile feedback improves performance and also if it speeds rehabilitation when used as an adjunct to conventional therapy.


Condition Intervention Phase
Vestibular Diseases
Peripheral Neuropathies
Proprioceptive Disorders
Hemispatial Neglect
Device: Vibrotactile feedback
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Evaluation of a Vibrotactile Sensory Aid Developed by the US Navy to Combat Pilot Disorientation as a Prosthesis in Patients With Postural Imbalance and Spatial Disorientation

Resource links provided by NLM:


Further study details as provided by Imperial College London:

Primary Outcome Measures:
  • Mean time reaction to the perturbation with the feedback

Estimated Enrollment: 30
Study Start Date: January 2005
Estimated Study Completion Date: December 2007
  Eligibility

Ages Eligible for Study:   50 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Sensory impairments
  • Unsteadiness

Exclusion Criteria:

  • High strokes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00146952

Contacts
Contact: Michael A Gresty, Pr 020-8846 ext 7634 m.gresty@imperial.ac.uk
Contact: Francois B Asseman, Dr 020-8383 ext 5525 f.asseman@imperial.ac.uk

Locations
United Kingdom
Charing Cross Hospital Recruiting
London, United Kingdom, W6 8RF
Contact: Michael A Gresty, Pr    020-8846 ext 7634    m.gresty@imperial.ac.uk   
Contact: Francois B Asseman, Dr    020-8383 ext 5525    f.asseman@imperial.ac.uk   
Principal Investigator: Michael A Gresty, Pr         
Sub-Investigator: Francois B Asseman, Dr         
Sponsors and Collaborators
Imperial College London
Medical Research Council
Investigators
Principal Investigator: Michael A Gresty, Pr Imperial College London
Study Director: Adolfo M Bronstein, Pr, MD Imperial College London
Study Director: Christopher Kennard, Pr, MD Imperial College London
Study Director: Masud Husain, Dr Imperial College London
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00146952     History of Changes
Other Study ID Numbers: DNMCA-PR1077
Study First Received: September 5, 2005
Last Updated: April 16, 2007
Health Authority: United Kingdom: Research Ethics Committee

Keywords provided by Imperial College London:
Hemineglects

Additional relevant MeSH terms:
Vestibular Diseases
Peripheral Nervous System Diseases
Confusion
Neuromuscular Diseases
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms
Labyrinth Diseases
Ear Diseases
Otorhinolaryngologic Diseases

ClinicalTrials.gov processed this record on October 19, 2014